Sergio Giralt, MD
Enriched profileDeputy Division Head, Division of Hematologic Malignancies; Melvin Berlin Family Chair in Multiple Myeloma; Chief Medical Officer, MSK Direct · Memorial Sloan Kettering Cancer Center
Sergio Giralt is Deputy Division Head, Division of Hematologic Malignancies; Melvin Berlin Family Chair in Multiple Myeloma; Chief Medical Officer, MSK Direct at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 1,809 publications with 63,367 citations (h-index 122); ClinicalTrials.gov lists 17 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Sergio Giralt, M.D., is Deputy Division Head, Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center, New York, NY. The public record shows 1,809 publications with 63,367 citations (h-index 122), centered on Hematopoietic Stem Cell Transplantation, Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 26 companies, 3 NIH-funded awards (2009–2023).
- Most recent indexed publication: 2026 · Blood
- Top research focus: Hematopoietic Stem Cell Transplantation
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 26 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 88 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 632.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- The Ambient Light Multiple Myeloma Study
Sponsor: Icahn School of Medicine at Mount Sinai
- Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
Sponsor: Medical College of Wisconsin
Industry payments
Updated 14 Oct 2026
26 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year20257 payments
- Gamida Cell Inc.Program year20251 payment
- CSL BehringProgram year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
38.3%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor38.3%Acyclovir100%Part D≥32 patientsMetabolism & gastrointestinal
24.2%Corticosteroid8.5%Prednisone100%Part D<11 patientsProton pump inhibitor8.1%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Anti-infectives
23%Short-acting sulfonamides23%Sulfamethoxazole-Trimethoprim100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
3 NIH research awards on record, funded 2009–2023 per NIH RePORTER. The latest:
- Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies
Sloan-Kettering Inst Can Research
FY2023$393,942P01CA023766 - Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies
Sloan-Kettering Inst Can Research
FY2022$386,125P01CA023766 - Project 6: Clinical Trials Focusing on Microbiota and Novel Cell Therapies
Sloan-Kettering Inst Can Research
FY2021$389,409P01CA023766
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantation.
Bone marrow transplantation
Letter2026 - Defining the Rates of Cytokine Release Syndrome Associated With Talquetamab Step-up Doses.
JCO oncology practice
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/sergio-giralt-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/sergio-giralt-72948812
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Sergio-Giralt
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - ResearchGate
researchgate.net/profile/Sergio-Giralt-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/sgiraltbmtdoc
Mentions by others
where others cite or feature them- Apple Podcasts
podcasts.apple.com/us/podcast/myeloma-crowd-radio-dr-sergio-giralt-md-memorial-sloan/id683926347
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - X / Twitter
x.com/mm_hub/status/1371064817180610561
- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Universidad Central de Venezuela
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Board Certified: Internal Medicine
Hematology, Medical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Internal Medicine Residency
Good Samaritan Hospital (Cincinnati)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Medical Oncology/Hematology Fellowship
MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
Experimental Hematology & Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ehoonline.biomedcentral.com ↗ - Editorial Board Member
Hematology, Transfusion and Cell Therapy
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journals.elsevier.com ↗ - Former Chair
Steering Committee, Blood and Marrow Transplant Clinical Trials Network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Former Chair
Myeloma Intergroup Committee, Blood and Marrow Transplant Clinical Trials Network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Former Chair
Center for International Blood and Marrow Transplant Research (CIBMTR)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Former Board of Directors Member
National Marrow Donor Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Secondary affiliations
appointments beyond the home institution- Former Deputy Chair
Department of Stem Cell Transplantation and Cellular Therapies, MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Former Medical Director
Blood and Marrow Transplant Center, MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Media & interviews
press, podcasts and appearances- Myeloma Crowd Radio / HealthTree Podcast for Multiple Myeloma
"Transplant Plus Options" interview (Nov 2016) and later HealthTree video appearance
2024provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myelomacrowd.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- "At Work: Adult Bone Marrow Transplant Service Chief Sergio Giralt"
MSK physician profile feature
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
Mark Kris, MD
Memorial Sloan Kettering Cancer Center
Kenneth Anderson, MD
Dana-Farber Cancer Institute
Paul Richardson, MD
Dana-Farber Cancer Institute
S Rajkumar, MD
Mayo Clinic
Meletios Dimopoulos, MD
National and Kapodistrian University of Athens